If no shareholders take up the offer and KOMODO takes up its...

First 7 Last

Share
Profile

Follow
riverbrae

2,515 Posts.

26/08/14

22:59

Post #: 13876856
Share

Originally posted by riverbrae ↑

Komodo’s present relevant interest (which is nil) and changes under several scenarios are set out in the table below and are based on the assumption that Komodo (or its nominee) takes up the maximum amount of shortfall it can under its sub-underwriting arrangements.

The Directors (other than Peter Landau who has a material personal interest in the Resolution) consider that Shareholder approval pursuant to Chapter 2E of the Corporations Act is not required in respect of Komodo’s sub-underwriting of the Offer because the Shares will be issued to Komodo (or its nominee) under the sub-underwriting arrangements on the same terms as Shares issued to non-related underwriters and sub-underwriters of the Offer and as such the giving of the financial benefit is considered to be on arm’s length terms.

RB

Expand

If no shareholders take up the offer and KOMODO takes up its full offer then Komodo will controll2,035,234,408 shares in CCC = to 26.04% of CCC

This plus ISSAR possible 63%> if not shareholders take up the offer gives the Underwriters of the offer 89>% of the company

SHAREHOLDERS ARE BEING DILUTED INTO OBLIVION

RB

CCC Price at posting: 2.0¢ Sentiment: Sell Disclosure: Held
1 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

'Not possible' to port renewable gas: ACCC takes AGN to court

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

First 7 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

If no shareholders take up the offer and KOMODO takes up its...

Top Stories

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

'Not possible' to port renewable gas: ACCC takes AGN to court

Australia’s gas crisis is here – and dying coal plants aren’t helping

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

Boss extends June win streak with boosted Alta Mesa extraction rates

Featured News